Target promotes the scholarly study of translational phenomena from a thoroughly interdisciplinary and international point of view. Rather than reducing research on translation to the practical questions asked by translators, their committers or their audience, the aim is to examine the role of translation in communication in general, with emphasis on cultural situations and theoretical, methodological and didactic matters. Attention is given to the relationship between translation and the societal organisation of communication. Target provides a forum for innovative approaches to translation. It publishes original studies on theoretical, methodological and descriptive-explanatory nature into translation problems and corpora, reflecting various socio-cultural approaches. The review section discusses the most important publications in the field in order to reflect the evolution of the discipline.
Despite the major efforts made in oncology over the past ten years, only relatively modest improvements have been made in the conventional treatment of cancer. Recently, a better understanding of molecular pathways has provided pathologists with clues to the parthenogenesis of the disease and multiple targets for new strategies. New treatments, monoclonal antibodies or small molecules, have emerged targeting these pathways and inhibiting tumor growth and progression. These 'mabs' and 'nibs' constitute a new language with its own grammar that oncologists have to learn. Significant work remains in controlling theses processes and understanding these new compounds. This journal aims to be a pragmatic tool for all physicians committed to the field, focusing on insight into the basic science of cellular functions, critical reviews of clinical data. The Société française d'angiogenèse is affiliated to the journal.